According to Cyclerion Therapeutics
's latest financial reports the company has $5.69 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $7.57 M | -43.42% |
2022-12-31 | $13.38 M | -75.2% |
2021-12-31 | $53.96 M | -0.8% |
2020-12-31 | $54.39 M | -42.68% |
2019-12-31 | $94.89 M | |
2018-12-31 | $N/A |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.31 B | 5,461.41% | ๐บ๐ธ USA |